Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 May 13;20(3):357–364. doi: 10.1016/j.repbio.2020.05.003

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Society for Biology of Reproduction & the Institute of Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn. Published by Elsevier B.V. All rights reserved.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 1 — Absolute weight of cauda epididymis (A) and seminal vesicle with fluid (B) of adult male Swiss mice orally treated for 15 (Control: n = 9; MET: n = 9) and 50 (Control: n = 10; MET: n = 11) days with methamidophos 0.004 mg.kg⁻¹. Values are mean ± standard deviation. Asterisk indicates a significant difference from control. Hash indicates a significant difference between 15 and 50 days of MET treatment. Factorial ANOVA and Tukey post-test (* P < 0.05, ^#P < 0.05).